Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin added to donepezil in mild to moderate Alzheimer's disease
2004-002007-33Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin, donepezil in Alzheimer's disease (AD), sponsored by Pfizer. Started Oct 2004; status: completed.
02
Drugs
atorvastatindonepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2004-002007-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002007-33.